Emerson Electric is one of those names that doesn't get talked about until it moves. Nobody had EMR on the tip of their tongue entering the week of April 21. Which is usually where I try to pay attention.
Update, 15 October 2026: the results
A correction first. Emerson did not report on 23 April, and $1.46 was not its print. Its fiscal second quarter, to 31 March, was released on 5 May: adjusted EPS of $1.54, up 4% and about a cent above consensus, on net sales of $4.56 billion, up 3%. Underlying sales rose only 0.5%, which the company put down to the conflict in the Middle East, while underlying orders rose 5%. The full-year adjusted EPS guide was $6.45–6.55. The stock closed at $138.38 that day, up 2.2%, then slid to $130.65 on 19 May.
The fiscal third quarter, to 30 June, reported on 4 August, was the beat-and-raise this trade was built on.
| Metric | Consensus / prior guide | Actual |
|---|---|---|
| Adjusted EPS | $1.68 | $1.71, +13% |
| Net sales | $4.79B | $4.87B, +7% |
| Underlying orders | — | +7% |
| Adjusted segment EBITA margin | — | 28.5%, +140bp |
| FY2026 adjusted EPS | $6.45–6.55 | ~$6.55 |
Lal Karsanbhai: "Emerson had an outstanding third quarter with sales, margin expansion, earnings and cash flow all exceeding expectations." The fourth-quarter guide is about $1.85 of adjusted EPS. The shares closed at $158.84 on 4 August, up 2.6%, reached a closing high of $164.38 on 11 August and closed at $161.08 on 14 October, 12.2% above my $143.60 exit.
What it changes. The automation thesis held: orders accelerated from 5% to 7% and the margin widened. The pullback toward $138–140 that I said I would watch for did come, in May, and went further, to $130.65; from there the stock gained 23%. Fiscal fourth-quarter results are due in November.
EMR Stock Thesis: Automation Meets AI Infrastructure
The automation and process control space has been grinding through a recovery since the inventory correction of 2023–2024. Emerson's transformation — shedding legacy businesses, refocusing on intelligent devices and software for industrial operations — has been deliberate and mostly unnoticed by the generalist crowd.
Going into Q1 2026 earnings (reported April 23), the setup looked asymmetric. Consensus EPS was $1.41. Implied volatility was modest. The business was not priced for a big beat, which meant any positive surprise had room to run. At $138.40, the stock was trading at roughly 22x forward earnings — not cheap, but reasonable for a company with genuine pricing power and a sticky software attach rate.
Entry and Execution
I initiated a long on April 22 at $138.40, one day before earnings. Size was deliberately moderate — this was a catalyst trade, not a core position build. My max loss framework was simple: if the stock broke below $134 on a disappointing print, I was wrong and I'd exit. I sized accordingly.
Q1 came in at $1.46 EPS against the $1.41 estimate. More importantly, management raised full-year guidance. That last part matters more than the beat itself. A one-quarter beat is a snapshot. A guidance raise is a statement about forward visibility — and in industrial automation, visibility is nearly everything.
The stock opened April 23 around $141.20 and continued to $143 by April 24. I exited at $143.60, locking in 3.76% from entry in two sessions.
Broader Context
What I was really paying for was the industrial automation cycle thesis becoming consensus. Emerson is not the only way to play this — Rockwell, ABB, Honeywell (in the automation division, separate from the messy Q2 guide) all have similar tailwinds — but it was the most attractively priced relative to its own recent history.
The position performed. What it also confirmed is that industrial automation spending in 2026 is accelerating, not just recovering. The data from Emerson's order book corroborates what I'm seeing across the sector.
I'll keep EMR on the watchlist for any pullback toward $138–140, which would represent a second opportunity to add with better timing and the same structural conviction.
— Ruslan Averin